
Management of Severe COVID-19 with Immunomodulators. Efficacy and Safety Issues
Author(s) -
Dalia Ashraf,
Maha M. Salem,
Norhan Abd El Mohsen,
Radwa El Borolossy,
Nagwa A. Sabri
Publication year - 2021
Publication title -
acta scientific pharmaceutical sciences
Language(s) - English
Resource type - Journals
ISSN - 2581-5423
DOI - 10.31080/asps.2021.05.0768
Subject(s) - cytokine storm , immune system , immunology , medicine , disease , cytokine , cytokine release syndrome , covid-19 , coronavirus , etiology , interleukin 6 , intensive care medicine , immunotherapy , infectious disease (medical specialty) , chimeric antigen receptor